Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV study

Yvonne Flores, Keerti Shah, Eduardo Lazcano, Mauricio Hernández, David Bishai, Daron G. Ferris, Attila Lörincz, Pilar Hernández, Jorge Salmerón, Mark E. Sherman, Brigitte M. Ronnett, Enrique Carmona, Alfredo Antúnez, Horacio Manzanares, Mario Uribe, Ricardo Pérez-Cuevas, Ahidee Leyva, Elsa Yunes

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objective. The purpose of this paper is to describe the design and methodology of the Morelos HPV Study. The main objective of this study is to examine the use of two different methods for obtaining HPV DNA specimens, self-collected vaginal and clinician-collected cervical, to detect pre-invasive cervical lesions and cancer. Material and Methods. This study was conducted within the regular population-based framework of the Mexican Institute of Social Security (IMSS) cervical cancer screening program in Morelos. A total of 7,868 women were recruited between May and October 1999 and are representative of the population of women attending cervical cancer screening services at the 23 IMSS clinics in the state of Morelos in 1999. Women were provided with a detailed description of the study before signing an informed consent form. Basic data were obtained from all participants using a standard IMSS registration form. During the initial recruitment visit, a randomly selected subsample of 1 069 participants were interviewed to collect additional information about cervical cancer risk factors, acceptability of the HPV and Pap tests, as well as patient costs. Before the pelvic exam, participants were asked to provide a self-collected vaginal specimen for HPV testing. All participants underwent a pelvic examination that involved collecting a cervical sample for the Pap smear and a clinician-collected HPV specimen. Data were evaluated from 7 732 women with complete information for the three tests. The 1 147 women who received at least one positive result (Pap, self- and/or clinician-HPV tests) were invited to return for a colposcopic examination. During colposcopy, biopsies were taken as appropriate, to histologically confirm a diagnosis of cervical intraepithelial neoplasia (CIN) 2/3 or invasive cancer. A total of 1,015 women attended colposcopy, and 101 women received a histologically-confirmed CIN 2/3 or cervical cancer diagnosis. Conclusions. The initial enrollment activities of the Morelos HPV study are the basis for a prevalent case-control study and a prospective cohort study that will investigate the natural history of HPV infections and determine if an HPV-based screening strategy is a safe and cost-effective alternative to Pap screening.

Original languageEnglish (US)
Pages (from-to)335-344
Number of pages10
JournalSalud Publica de Mexico
Volume44
Issue number4
StatePublished - Jul 2002
Externally publishedYes

Fingerprint

Mexico
Early Detection of Cancer
Uterine Cervical Neoplasms
Papanicolaou Test
Gynecological Examination
Colposcopy
Cervical Intraepithelial Neoplasia
Consent Forms
Costs and Cost Analysis
Social Security
Natural History
Population
Case-Control Studies
Cohort Studies
Prospective Studies
Biopsy
DNA
Infection
Neoplasms

Keywords

  • Cervical cancer
  • HPV
  • México
  • Papanicolaou
  • Screening

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Flores, Y., Shah, K., Lazcano, E., Hernández, M., Bishai, D., Ferris, D. G., ... Yunes, E. (2002). Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV study. Salud Publica de Mexico, 44(4), 335-344.

Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico : The Morelos HPV study. / Flores, Yvonne; Shah, Keerti; Lazcano, Eduardo; Hernández, Mauricio; Bishai, David; Ferris, Daron G.; Lörincz, Attila; Hernández, Pilar; Salmerón, Jorge; Sherman, Mark E.; Ronnett, Brigitte M.; Carmona, Enrique; Antúnez, Alfredo; Manzanares, Horacio; Uribe, Mario; Pérez-Cuevas, Ricardo; Leyva, Ahidee; Yunes, Elsa.

In: Salud Publica de Mexico, Vol. 44, No. 4, 07.2002, p. 335-344.

Research output: Contribution to journalArticle

Flores, Y, Shah, K, Lazcano, E, Hernández, M, Bishai, D, Ferris, DG, Lörincz, A, Hernández, P, Salmerón, J, Sherman, ME, Ronnett, BM, Carmona, E, Antúnez, A, Manzanares, H, Uribe, M, Pérez-Cuevas, R, Leyva, A & Yunes, E 2002, 'Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV study', Salud Publica de Mexico, vol. 44, no. 4, pp. 335-344.
Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG et al. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV study. Salud Publica de Mexico. 2002 Jul;44(4):335-344.
Flores, Yvonne ; Shah, Keerti ; Lazcano, Eduardo ; Hernández, Mauricio ; Bishai, David ; Ferris, Daron G. ; Lörincz, Attila ; Hernández, Pilar ; Salmerón, Jorge ; Sherman, Mark E. ; Ronnett, Brigitte M. ; Carmona, Enrique ; Antúnez, Alfredo ; Manzanares, Horacio ; Uribe, Mario ; Pérez-Cuevas, Ricardo ; Leyva, Ahidee ; Yunes, Elsa. / Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico : The Morelos HPV study. In: Salud Publica de Mexico. 2002 ; Vol. 44, No. 4. pp. 335-344.
@article{ddc691097c194ca697bbd9ede1d40d30,
title = "Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV study",
abstract = "Objective. The purpose of this paper is to describe the design and methodology of the Morelos HPV Study. The main objective of this study is to examine the use of two different methods for obtaining HPV DNA specimens, self-collected vaginal and clinician-collected cervical, to detect pre-invasive cervical lesions and cancer. Material and Methods. This study was conducted within the regular population-based framework of the Mexican Institute of Social Security (IMSS) cervical cancer screening program in Morelos. A total of 7,868 women were recruited between May and October 1999 and are representative of the population of women attending cervical cancer screening services at the 23 IMSS clinics in the state of Morelos in 1999. Women were provided with a detailed description of the study before signing an informed consent form. Basic data were obtained from all participants using a standard IMSS registration form. During the initial recruitment visit, a randomly selected subsample of 1 069 participants were interviewed to collect additional information about cervical cancer risk factors, acceptability of the HPV and Pap tests, as well as patient costs. Before the pelvic exam, participants were asked to provide a self-collected vaginal specimen for HPV testing. All participants underwent a pelvic examination that involved collecting a cervical sample for the Pap smear and a clinician-collected HPV specimen. Data were evaluated from 7 732 women with complete information for the three tests. The 1 147 women who received at least one positive result (Pap, self- and/or clinician-HPV tests) were invited to return for a colposcopic examination. During colposcopy, biopsies were taken as appropriate, to histologically confirm a diagnosis of cervical intraepithelial neoplasia (CIN) 2/3 or invasive cancer. A total of 1,015 women attended colposcopy, and 101 women received a histologically-confirmed CIN 2/3 or cervical cancer diagnosis. Conclusions. The initial enrollment activities of the Morelos HPV study are the basis for a prevalent case-control study and a prospective cohort study that will investigate the natural history of HPV infections and determine if an HPV-based screening strategy is a safe and cost-effective alternative to Pap screening.",
keywords = "Cervical cancer, HPV, M{\'e}xico, Papanicolaou, Screening",
author = "Yvonne Flores and Keerti Shah and Eduardo Lazcano and Mauricio Hern{\'a}ndez and David Bishai and Ferris, {Daron G.} and Attila L{\"o}rincz and Pilar Hern{\'a}ndez and Jorge Salmer{\'o}n and Sherman, {Mark E.} and Ronnett, {Brigitte M.} and Enrique Carmona and Alfredo Ant{\'u}nez and Horacio Manzanares and Mario Uribe and Ricardo P{\'e}rez-Cuevas and Ahidee Leyva and Elsa Yunes",
year = "2002",
month = "7",
language = "English (US)",
volume = "44",
pages = "335--344",
journal = "Salud Publica de Mexico",
issn = "0036-3634",
publisher = "Instituto Nacional de Salud Publica",
number = "4",

}

TY - JOUR

T1 - Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico

T2 - The Morelos HPV study

AU - Flores, Yvonne

AU - Shah, Keerti

AU - Lazcano, Eduardo

AU - Hernández, Mauricio

AU - Bishai, David

AU - Ferris, Daron G.

AU - Lörincz, Attila

AU - Hernández, Pilar

AU - Salmerón, Jorge

AU - Sherman, Mark E.

AU - Ronnett, Brigitte M.

AU - Carmona, Enrique

AU - Antúnez, Alfredo

AU - Manzanares, Horacio

AU - Uribe, Mario

AU - Pérez-Cuevas, Ricardo

AU - Leyva, Ahidee

AU - Yunes, Elsa

PY - 2002/7

Y1 - 2002/7

N2 - Objective. The purpose of this paper is to describe the design and methodology of the Morelos HPV Study. The main objective of this study is to examine the use of two different methods for obtaining HPV DNA specimens, self-collected vaginal and clinician-collected cervical, to detect pre-invasive cervical lesions and cancer. Material and Methods. This study was conducted within the regular population-based framework of the Mexican Institute of Social Security (IMSS) cervical cancer screening program in Morelos. A total of 7,868 women were recruited between May and October 1999 and are representative of the population of women attending cervical cancer screening services at the 23 IMSS clinics in the state of Morelos in 1999. Women were provided with a detailed description of the study before signing an informed consent form. Basic data were obtained from all participants using a standard IMSS registration form. During the initial recruitment visit, a randomly selected subsample of 1 069 participants were interviewed to collect additional information about cervical cancer risk factors, acceptability of the HPV and Pap tests, as well as patient costs. Before the pelvic exam, participants were asked to provide a self-collected vaginal specimen for HPV testing. All participants underwent a pelvic examination that involved collecting a cervical sample for the Pap smear and a clinician-collected HPV specimen. Data were evaluated from 7 732 women with complete information for the three tests. The 1 147 women who received at least one positive result (Pap, self- and/or clinician-HPV tests) were invited to return for a colposcopic examination. During colposcopy, biopsies were taken as appropriate, to histologically confirm a diagnosis of cervical intraepithelial neoplasia (CIN) 2/3 or invasive cancer. A total of 1,015 women attended colposcopy, and 101 women received a histologically-confirmed CIN 2/3 or cervical cancer diagnosis. Conclusions. The initial enrollment activities of the Morelos HPV study are the basis for a prevalent case-control study and a prospective cohort study that will investigate the natural history of HPV infections and determine if an HPV-based screening strategy is a safe and cost-effective alternative to Pap screening.

AB - Objective. The purpose of this paper is to describe the design and methodology of the Morelos HPV Study. The main objective of this study is to examine the use of two different methods for obtaining HPV DNA specimens, self-collected vaginal and clinician-collected cervical, to detect pre-invasive cervical lesions and cancer. Material and Methods. This study was conducted within the regular population-based framework of the Mexican Institute of Social Security (IMSS) cervical cancer screening program in Morelos. A total of 7,868 women were recruited between May and October 1999 and are representative of the population of women attending cervical cancer screening services at the 23 IMSS clinics in the state of Morelos in 1999. Women were provided with a detailed description of the study before signing an informed consent form. Basic data were obtained from all participants using a standard IMSS registration form. During the initial recruitment visit, a randomly selected subsample of 1 069 participants were interviewed to collect additional information about cervical cancer risk factors, acceptability of the HPV and Pap tests, as well as patient costs. Before the pelvic exam, participants were asked to provide a self-collected vaginal specimen for HPV testing. All participants underwent a pelvic examination that involved collecting a cervical sample for the Pap smear and a clinician-collected HPV specimen. Data were evaluated from 7 732 women with complete information for the three tests. The 1 147 women who received at least one positive result (Pap, self- and/or clinician-HPV tests) were invited to return for a colposcopic examination. During colposcopy, biopsies were taken as appropriate, to histologically confirm a diagnosis of cervical intraepithelial neoplasia (CIN) 2/3 or invasive cancer. A total of 1,015 women attended colposcopy, and 101 women received a histologically-confirmed CIN 2/3 or cervical cancer diagnosis. Conclusions. The initial enrollment activities of the Morelos HPV study are the basis for a prevalent case-control study and a prospective cohort study that will investigate the natural history of HPV infections and determine if an HPV-based screening strategy is a safe and cost-effective alternative to Pap screening.

KW - Cervical cancer

KW - HPV

KW - México

KW - Papanicolaou

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=0036650465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036650465&partnerID=8YFLogxK

M3 - Article

C2 - 12216521

AN - SCOPUS:0036650465

VL - 44

SP - 335

EP - 344

JO - Salud Publica de Mexico

JF - Salud Publica de Mexico

SN - 0036-3634

IS - 4

ER -